Where does Orbusneich Medical Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Orbusneich Medical Inc. ranks #17,975 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Orbusneich Medical Inc. hold?

Orbusneich Medical Inc. holds 16 US utility patents granted between 2015 and 2018, spanning 13 technology areas.

What is Orbusneich Medical Inc.'s Innovation Score?

Orbusneich Medical Inc. has an Innovation Score of 30.4 out of 100 (34th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Orbusneich Medical Inc.'s patent grant rate increasing or decreasing?

Orbusneich Medical Inc.'s recent grant velocity is -100% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Orbusneich Medical Inc.'s patents?

Orbusneich Medical Inc.'s patents average 13.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Orbusneich Medical Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Orbusneich Medical Inc.

Q: What technology areas does Orbusneich Medical Inc. focus on?

Orbusneich Medical Inc.'s top technology area is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs) with 14 patents, ranking #463 of 3,082 assignees active in that subclass. Grants appear in 13 CPC subclasses total.

USPTO PatentsView assignee record - 16 granted patents across 13 technology areas, recorded in grant years 2015–2018. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Orbusneich ranks #17,975 of 49,997 tracked US assignees by granted-patent volume, with 16 patents across 13 technology areas.

#17,975
of 49,997 US assignees by volume: 34th percentile
by Innovation Score (30.4/100): 13.1
avg claims per patent: -100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R17975 · US Corporation #17,975 · 16 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 16 grants
MID-PACK #17,975/49,997
PHOTO-FINISH ObservePoint
CPC-FOCUS A61F · 13 areas
INNOV-THIN 30.4/100
CLAIMS-RICH 13.1 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: ObservePoint, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Orbusneich’s 30.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.8 pts (32%) Velocity 0.0 pts (0%) Breadth 12.7 pts (42%) Claim depth 7.8 pts (26%)

Qualcomm Incorporated · highest

85
Orbusneich Medical · this assignee

30
3D Lighting… · lowest

7

What this shows Orbusneich's Innovation Score is 30.4/100 (34th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Orbusneich?

Each dot is one of Orbusneich’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Orbusneich’s own 13.1 claims/patent is at or below the 15.6 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Orbusneich vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Orbusneich's grants concentrate

Orbusneich Medical Inc. is a focused PatentsView assignee: 13 CPC subclasses with 87.5% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2017 (8 grants) versus a trough of 1 in 2018. By volume, Orbusneich sits between Octane Biotech Inc. and ObservePoint, Inc..

Octane Biotech

16
Omnilife science

16
Onera (Office Nat…

16
Opko Renal

16
Orbusneich Medica…

16
Ortho Solutions H…

16
OUR Pet's

16
Observepoint

16
Orbusneich Medical ◀

16

What this shows Orbusneich holds 16 patents at rank #17,961, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Orbusneich

By rank, the assignees closest to #17,961 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Orbusneich's primary technology class.

Orbusneich's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

30 34th percentile higher than 34% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2018

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Orbusneich Medical Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	12.5%
2016	5	31.3%
2017	8	50.0%
2018	1	6.3%

Which technologies does Orbusneich Medical Inc. patent most?

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 14

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 11

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 7

B29L - Indexing Scheme Associated With Subclass B29c, Relating TO Particular Articles 5

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 5

B29K - Indexing Scheme Associated With Subclasses B29b, B29c OR B29d, Relating TO Moulding Materials OR TO Materials FOR ; Moulds, ; Reinforcements, Fillers OR Preformed Parts, e.g. Inserts 5

C08G - Macromolecular Compounds Obtained Otherwise Than BY Reactions Only Involving Unsaturated Carbon-to-carbon Bonds 4

C08L - Compositions OF Macromolecular Compounds 4

Y10T - Technical Subjects Covered BY Former US Classification 4

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 3

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 2

B82Y - Specific Uses OR Applications OF NANOSTRUCTURES; Measurement OR Analysis OF NANOSTRUCTURES; Manufacture OR Treatment OF Nanostructures 2

C07K - Peptides 1

Top 13 of 13 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Orbusneich Medical Inc.'s patent record in context - here's where to go next.

Orbusneich Medical Inc.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 87.5% of its portfolio - see every assignee active in that class. Explore A61F
Ranked #17,975 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Orbusneich Medical Inc. against Octane Biotech Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 30.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.